帕金森综合征康复中的肌肉靶向营养支持
这项务实、双中心、随机、评估者盲法对照试验纳入150例接受30天多学科强化康复治疗的帕金森病或帕金森综合征患者,比较标准饮食联合或不联合富含亮氨酸和维生素D的乳清蛋白营养补充剂的效果。营养支持组6分钟步行试验距离增幅大于对照组,差异为18.1米(95%CI 0.9-35.3,p=0.039),4米步行速度、TUG及骨骼肌质量等次要终点也显示获益。
要点
- 乳清蛋白联合亮氨酸和维生素D补充可改善接受强化康复患者的步行能力。
- 6分钟步行距离组间差异18.1米(95%CI 0.9-35.3,p=0.039)。
- 6例因轻度不良反应停用营养治疗。
核心结论
- 对接受多学科强化康复治疗的帕金森病或帕金森综合征患者,补充富含亮氨酸和维生素D的乳清蛋白配方可改善下肢功能并保持肌肉质量。
研究设计与样本
- 务实、双中心、随机(1:1)、评估者盲法对照试验(PRO-LEADER),2017年4月至2018年1月,纳入150例认知完整的帕金森病或帕金森综合征患者,均接受30天多学科强化康复治疗。
主要发现
- 营养支持组6分钟步行试验距离平均增加69.6米(95%CI 60.7-78.6),无支持组增加51.8米(95%CI 37.0-66.7),中心校正后平均差异18.1米(95%CI 0.9-35.3,p=0.039)。
- 进一步校正多巴胺能治疗和骨骼肌质量变化后结果一致:平均差异18.0米(95%CI 0.7-35.2,p=0.043)。
- 4米步行速度(p=0.032)、TUG(p=0.046)、骨骼肌质量及骨骼肌质量指数(p=0.029)等次要终点也显示有意义的效应。
关键数值与推荐
- 主要终点为6分钟步行试验距离的增加;次要终点包括4米步行速度、TUG、Berg平衡量表、握力、自我评估帕金森病残疾量表、体重和骨骼肌质量。
- 营养补充方案为每日两次乳清蛋白为基础的营养补充剂,富含亮氨酸和维生素D,联合标准医院饮食。
临床怎么用
- 对接受强化康复的帕金森病或帕金森综合征患者,可考虑联合富含亮氨酸和维生素D的乳清蛋白营养补充以改善步行能力和维持肌肉质量。
局限性
- 6例患者因轻度不良反应停用营养治疗;研究为30天干预,长期效果未报告。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: We evaluated the efficacy of muscle-targeted nutritional support on the functional outcomes of multidisciplinary intensive rehabilitation treatment (MIRT) in patients with Parkinson disease (PD) or parkinsonism. METHODS: We conducted a pragmatic, bicentric, randomized (1:1), assessor-blind controlled trial (Protein, Leucine and Vitamin D Enhancing Rehabilitation [PRO-LEADER]; April 2017 to January 2018) in cognitively intact patients with PD or parkinsonism and undergoing a 30-day MIRT. Patients (n = 150) received a standard hospital diet with or without a whey protein-based nutritional supplement enriched with leucine and vitamin D twice daily. The primary efficacy endpoint was the increase in the distance walked during a 6-minute walking test (6MWT). Secondary endpoints were changes in 4-meter walking speed, Timed Up and Go test (TUG), Berg balance scale, handgrip strength, Self-assessment Parkinson's Disease Disability Scale, body weight, and skeletal muscle mass (SMM). RESULTS: Nutritional support resulted in greater increase in the distance walked during 6MWT (mean 69.6 meters [95% confidence interval (CI) 60.7-78.6]) than no support (51.8 meters [95% CI 37.0-66.7]): center-adjusted mean difference, 18.1 meters (95% CI 0.9-35.3) (p = 0.039). Further adjustment for changes in dopaminergic therapy and SMM yielded consistent results: mean difference, 18.0 meters (95% CI 0.7-35.2) (p = 0.043). A meaningful effect was also found for the following secondary endpoints: 4-meter walking speed (p = 0.032), TUG (p = 0.046), SMM, and SMM index (p = 0.029). Six patients discontinued the nutritional therapy due to mild side effects. CONCLUSION: The consumption of a whey protein-based nutritional formula enriched with leucine and vitamin D with MIRT improved lower extremity function and preserved muscle mass in patients with PD or parkinsonism.Clinicaltrials.gov IDENTIFIER: NCT03124277. CLASSIFICATION OF EVIDENCE: This study provides Class I evidence that for patients with parkinsonism undergoing intensive rehabilitation, a whey protein-based nutritional formula enriched with leucine and vitamin D increased distance walked on the 6MWT.
引用
- Barichella M, Cereda E, Pinelli G, et al. Muscle-targeted nutritional support for rehabilitation in patients with parkinsonian syndrome. Neurology. 2019. PMID: 31278117. doi:10.1212/WNL.0000000000007858
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。